ClinVar Genomic variation as it relates to human health
NM_001351132.2(PEX5):c.1578T>G (p.Asn526Lys)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_001351132.2(PEX5):c.1578T>G (p.Asn526Lys)
Variation ID: 9143 Accession: VCV000009143.8
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 12p13.31 12: 7209700 (GRCh38) [ NCBI UCSC ] 12: 7362296 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Mar 8, 2017 Feb 4, 2024 May 8, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_001351132.2:c.1578T>G MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_001338061.1:p.Asn526Lys missense NM_000319.5:c.1554T>G NP_000310.2:p.Asn518Lys missense NM_001131023.2:c.1623T>G NP_001124495.1:p.Asn541Lys missense NM_001131024.2:c.1467T>G NP_001124496.1:p.Asn489Lys missense NM_001131025.2:c.1578T>G NP_001124497.1:p.Asn526Lys missense NM_001131026.2:c.1578T>G NP_001124498.1:p.Asn526Lys missense NM_001300789.3:c.1578T>G NP_001287718.2:p.Asn526Lys missense NM_001351124.3:c.1467T>G NP_001338053.1:p.Asn489Lys missense NM_001351126.2:c.1467T>G NP_001338055.1:p.Asn489Lys missense NM_001351127.2:c.1467T>G NP_001338056.1:p.Asn489Lys missense NM_001351128.2:c.1467T>G NP_001338057.1:p.Asn489Lys missense NM_001351130.3:c.1467T>G NP_001338059.1:p.Asn489Lys missense NM_001351131.2:c.1578T>G NP_001338060.1:p.Asn526Lys missense NM_001351133.2:c.1578T>G NP_001338062.1:p.Asn526Lys missense NM_001351134.2:c.1578T>G NP_001338063.1:p.Asn526Lys missense NM_001351135.3:c.1512T>G NP_001338064.2:p.Asn504Lys missense NM_001351136.2:c.1569T>G NP_001338065.1:p.Asn523Lys missense NM_001351137.3:c.1467T>G NP_001338066.2:p.Asn489Lys missense NM_001351138.2:c.1512T>G NP_001338067.1:p.Asn504Lys missense NM_001351139.2:c.1443T>G NP_001338068.1:p.Asn481Lys missense NM_001351140.2:c.1443T>G NP_001338069.1:p.Asn481Lys missense NM_001374645.1:c.1467T>G NP_001361574.1:p.Asn489Lys missense NM_001374646.1:c.1467T>G NP_001361575.1:p.Asn489Lys missense NM_001374647.2:c.1578T>G NP_001361576.1:p.Asn526Lys missense NM_001374648.2:c.1467T>G NP_001361577.1:p.Asn489Lys missense NM_001374649.2:c.1443T>G NP_001361578.1:p.Asn481Lys missense NC_000012.12:g.7209700T>G NC_000012.11:g.7362296T>G NG_008448.1:g.25538T>G - Protein change
- N489K, N518K, N526K, N541K, N547K, N523K, N481K, N504K
- Other names
- -
- Canonical SPDI
- NC_000012.12:7209699:T:G
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
PEX5 | - | - |
GRCh38 GRCh38 GRCh37 |
991 | 1043 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Pathogenic (2) |
no assertion criteria provided
|
Jun 26, 2018 | RCV000009714.3 | |
Pathogenic/Likely pathogenic (2) |
criteria provided, multiple submitters, no conflicts
|
Nov 19, 2021 | RCV000427819.6 | |
Pathogenic (3) |
criteria provided, multiple submitters, no conflicts
|
May 8, 2023 | RCV000723322.4 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Pathogenic
(May 15, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Peroxisome biogenesis disorder 2A (Zellweger)
Affected status: yes
Allele origin:
unknown
|
Baylor Genetics
Accession: SCV001525319.1
First in ClinVar: Mar 22, 2021 Last updated: Mar 22, 2021 |
Comment:
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].
|
|
Pathogenic
(Mar 28, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000516541.4
First in ClinVar: Mar 08, 2017 Last updated: Jul 24, 2021 |
Comment:
Published functional studies demonstrate a damaging effect (Dodt et al., 1995; Shimozawa et al., 1999; Carvalho et al., 2007); Not observed in large population cohorts … (more)
Published functional studies demonstrate a damaging effect (Dodt et al., 1995; Shimozawa et al., 1999; Carvalho et al., 2007); Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 31130284, 11101887, 7719337, 10462504, 18712838, 17532062) (less)
|
|
Likely pathogenic
(Nov 19, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: unknown
Allele origin:
germline
|
Revvity Omics, Revvity
Accession: SCV003811354.2
First in ClinVar: Mar 04, 2023 Last updated: Feb 04, 2024 |
|
|
Pathogenic
(May 08, 2023)
|
criteria provided, single submitter
Method: research
|
Peroxisome biogenesis disorder 2A (Zellweger)
Affected status: yes
Allele origin:
germline
|
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center
Accession: SCV003924308.1
First in ClinVar: May 20, 2023 Last updated: May 20, 2023 |
|
|
Pathogenic
(Feb 01, 1995)
|
no assertion criteria provided
Method: literature only
|
PEROXISOME BIOGENESIS DISORDER 2B
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000029932.2
First in ClinVar: Apr 04, 2013 Last updated: Aug 24, 2018 |
Comment on evidence:
In a cell line from a patient with neonatal adrenoleukodystrophy (see PBD2B, 202370), Dodt et al. (1995) identified a specific defect in PTS1-mediated uptake of … (more)
In a cell line from a patient with neonatal adrenoleukodystrophy (see PBD2B, 202370), Dodt et al. (1995) identified a specific defect in PTS1-mediated uptake of peroxisomal proteins and examined the PXR1 gene in this patient by RT-PCR amplification of fibroblast RNA followed by SSCP analysis. Sequencing of an abnormally migrating fragment demonstrated a PXR1 allele with a T-to-G transversion at basepair 1467, producing an asn489-to-lys (N489K) substitution. The patient appeared to be homozygous for the mutant allele, but family studies were not performed. The N489K substitution was not found in 130 unrelated control individuals. Transfection of the normal gene into the patient's cells restored normal import of PTS1-containing proteins into peroxisomes, as well as normal peroxisome morphology. In contrast, normal cells transfected with PXR1 carrying the N489K mutation were unable to import PTS1-containing proteins into peroxisomes. (The cells of the patient showed normal import of the PTS2 marker protein, thiolase, into peroxisomal structures.) (less)
|
|
Pathogenic
(Jun 26, 2018)
|
no assertion criteria provided
Method: clinical testing
|
Peroxisome biogenesis disorder 2A (Zellweger)
Affected status: yes
Allele origin:
germline
|
Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City
Accession: SCV000854715.1
First in ClinVar: Dec 09, 2018 Last updated: Dec 09, 2018 |
|
|
Pathogenic
(Jun 26, 2018)
|
no assertion criteria provided
Method: clinical testing
|
Peroxisome biogenesis disorder 2B
Affected status: yes
Allele origin:
germline
|
Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City
Accession: SCV000854716.1
First in ClinVar: Aug 24, 2018 Last updated: Aug 24, 2018 |
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders. | Dodt G | Nature genetics | 1995 | PMID: 7719337 |
Text-mined citations for rs61752138 ...
HelpRecord last updated Aug 04, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.